Leaflet LEVOPRONT 60mg tablets


Indicated for: dry cough

Substance: levodropropysin (expectorant)

ATC: R05DB27 (Respiratory system | Cough suppressants, excl. combinations with expectorants | Other cough suppressants)

Levodropropizine is a medication used to treat non-productive (dry) cough. It works by inhibiting the cough reflex at both central and peripheral levels without affecting respiratory activity.

The medication is taken orally, usually in syrup form, and the dosage is adjusted based on the patient's age and weight. It is recommended for short-term use until symptoms improve.

Side effects may include drowsiness, dizziness, nausea, or allergic reactions. In rare cases, more severe adverse effects such as breathing difficulties may occur.

Patients should avoid alcohol consumption and inform their doctor about any other medications they are taking. Pregnant or breastfeeding women should consult a specialist before use.

General data about LEVOPRONT 60mg

  • Substance: levodropropysin
  • Date of last drug list: 01-12-2020
  • Commercial code: W66910001
  • Concentration: 60mg
  • Pharmaceutical form: tablets
  • Quantity: 10
  • Product type: generic
  • Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Marketing authorisation

  • Manufacturer: ABIOGEN PHARMA S.P.A. - ITALIA
  • Holder: DOMPE FARMACEUTICI S.P.A. - ITALIA
  • Number: 12742/2019/01
  • Shelf life: 3 years

Pharmaceutical forms available for levodropropysin

Concentrations available for levodropropysin

  • 0.6%
  • 30mg/5ml
  • 60mg
  • 60mg/ml